glp-1 nhs Medications Infographic GLP-1 Drugs On The NHS:

DJM is supported by a National Health and Medical Research Council senior research fellowship

Menter A, Cram DL

Black Box Warning GLP-1 receptor agonists are contraindicated in individuals with: A history of medullary thyroid carcinoma (MTC), A family history of MTC, or Multiple endocrine neoplasia syndrome type 2 (MEN2)

Compliance: This product is sold strictly for research purposes only

Although a direct causal link between NAD+ supplementation and cancer progression has not been proven, experts recommend that patients with an ongoing cancer or a history of cancer only consider NAD+ therapy with clearance from their oncologist